Yttrium-90 Radioembolization of Hepatocellular Carcinoma and Metastatic Disease to the Liver

ABSTRACT

Yttrium-90 (⁹⁰Y) radioembolization is a catheter-based therapy that delivers internal radiation to hepatic tumors in the form of microspheres. ⁹⁰Y can be delivered to the hepatic tumor as either a constituent of a glass microsphere, TheraSphere^®, or as a biocompatible resin-based microsphere, SIR-Spheres^®. Once embedded within the tumor microcirculation, these microspheres emit β-radiation at therapeutic levels. While the technical aspects of radioembolization are quite complex, the collective clinical experience presented in the literature supports the use of ⁹⁰Y radioembolization for unresectable hepatic malignancies.

TheraSphere^® - SIR-Sphere^® - radioembolization - yttrium-90 - hepatocellular carcinoma - metastatic disease to the liver - liver cancer - liver tumor

REFERENCES

• 1 Goin J E, Salem R, Carr B I et al.. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities.  J Vasc Interv Radiol. 2005;  16 205-213
• 2 Breedis C, Young G. The blood supply of neoplasms in the liver.  Am J Pathol. 1954;  30 969-977
• 3 Schenk Jr W G, McDonald J C, McDonald K, Drapanas T. Direct measurement of hepatic blood flow in surgical patients.  Ann Surg. 1962;  156 463-471
• 4 Lin G, Lunderquist A, Hägerstrand I, Boijsen E. Postmortem examination of the blood supply and vascular pattern of small liver metastases in man.  Surgery. 1984;  96 517-526
• 5 Grindlay J H, Mann F C. Measurement of the blood flow of the liver.  Am J Physiol. 1941;  132 489-496
• 6 Tygstrup N, Winkler K, Mellemgaard K, Andreassen M. Determination of the hepatic arterial blood flow and oxygen supply in man by clamping the hepatic artery during surgery.  J Clin Invest. 1962;  41 447-454
• 7 Almersjo O, Bengmark S, Engevik L, Hafstrom L O, Nilsson L A. Hepatic artery ligation as pretreatment for liver resection of metastatic cancer.  Rev Surg. 1966;  23 377-380
• 8 Bierman H R, Byron Jr R L, Kelley K H, Grady A. Studies on the blood supply of tumors in man. III: vascular patterns of the liver by hepatic arteriography in vivo.  J Natl Cancer Inst. 1951;  12 107-131
• 9 Healey Jr J E. Vascular patterns in human metastatic liver tumors.  Surg Gynecol Obstet. 1965;  120 1187-1193
• 10 Lewin K, Millis R R. Human radiation hepatitis: a morphologic study with emphasis on the late changes.  Arch Pathol. 1973;  96 21-26
• 11 Andrews J C, Walker S C, Ackermann R J, Cotton L A, Ensminger W D, Shapiro B. Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up.  J Nucl Med. 1994;  35 1637-1644
• 12 Sarfaraz M, Kennedy A S, Cao Z J et al.. Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors.  Med Phys. 2003;  30 199-203
• 13 Dancey J E, Shepherd F A, Paul K et al.. Treatment of nonresectable hepatocellular carcinoma with intrahepatic ⁹⁰Y-microspheres.  J Nucl Med. 2000;  41 1673-1681
• 14 Goin J E, Dancey J E, Hermamm G A et al.. Treatment of unresectable metastatic colorectal carcinoma to the liver with intrahepatic Y-90 microspheres: a dose-ranging study.  World J Nucl Med. 2003;  2 216-225
• 15 Yttrium-90 microspheres (TheraSphere^®) [package insert]. Kanata, Canada; MDS Nordion 2004
• 16 Kennedy A S, Nutting C, Coldwell D, Gaiser J, Drachenberg C. Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers.  Int J Radiat Oncol Biol Phys. 2004;  60 1552-1563
• 17 Salem R, Thurston K G, Carr B I, Goin J E, Geschwind J F. Yttrium-90 microspheres: radiation therapy for unresectable liver cancer.  J Vasc Interv Radiol. 2002;  13 S223-S229
• 18 Yttrium-90 microspheres (SIR-Spheres^®) [package insert]. Lane Cove, Australia; Sirtex Medical 2004
• 19 Van Hazel G, Blackwell A, Anderson J et al.. Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer.  J Surg Oncol. 2004;  88 78-85
• 20 Liu D M, Salem R, Bui J T et al.. Angiographic considerations in patients undergoing liver-directed therapy.  J Vasc Interv Radiol. 2005;  16 911-935
• 21 Soresi M, Magliarisi C, Campagna P et al.. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.  Anticancer Res. 2003;  23 1747-1753
• 22 Salem R, Lewandowski R, Roberts C et al.. Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis.  J Vasc Interv Radiol. 2004;  15 335-345
• 23 Carr B I. Hepatic artery chemoembolization for advanced stage HCC: experience of 650 patients.  Hepatogastroenterology. 2002;  49 79-86
• 24 Chun H J, Byun J Y, Yoo S S, Choi B G. Added benefit of thoracic aortography after transarterial embolization in patients with hemoptysis.  AJR Am J Roentgenol. 2003;  180 1577-1581
• 25 Chung J W, Park J H, Han J K et al.. Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization.  Radiology. 1996;  198 33-40
• 26 Inaba Y, Arai Y, Matsueda K, Takeuchi Y, Aramaki T. Right gastric artery embolization to prevent acute gastric mucosal lesions in patients undergoing repeat hepatic arterial infusion chemotherapy.  J Vasc Interv Radiol. 2001;  12 957-963
• 27 Ueno K, Miyazono N, Inoue H, Miyake S, Nishida H, Nakajo M. Embolization of the hepatic falciform artery to prevent supraumbilical skin rash during transcatheter arterial chemoembolization for hepatocellular carcinoma.  Cardiovasc Intervent Radiol. 1995;  18 183-185
• 28 Arora R, Soulen M C, Haskal Z J. Cutaneous complications of hepatic chemoembolization via extrahepatic collaterals.  J Vasc Interv Radiol. 1999;  10 1351-1356
• 29 Leung T W, Lau W Y, Ho S K et al.. Radiation pneumonitis after selective internal radiation treatment with intra-arterial 90-yttrium-microspheres for inoperable hepatic tumors.  Int J Radiat Oncol Biol Phys. 1995;  33 919-924
• 30 American Cancer Society .Cancer Facts and Figures 2004. Atlanta; A.P. 2004
• 31 Salem R, Hunter R. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: a review.  Int J Radiat Oncol Biol Phys. 2005;  , In press
• 32 Kulik L M, Mulcahy M F, Hunter R D, Nemcek Jr A A, Abecassis M M, Salem R. Use of yttrium-90 microspheres (TheraSphere) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: a case report.  Liver Transpl. 2005;  11 1127-1131
• 33 Salem R, Lewandowski R J, Atassi B et al.. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival.  J Vasc Interv Radiol. 2005;  16 1627-1639
• 34 Geschwind J F, Salem R, Carr B I et al.. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma.  Gastroenterology. 2004;  127(suppl 1) S194-S205
• 35 Carr B I. Hepatic arterial ⁹⁰Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients.  Liver Transpl. 2004;  10(suppl 1) S107-S110
• 36 Lim L, Gibbs P, Yip D et al.. Prospective study of treatment with selective internal radiation therapy spheres in patients with unresectable primary or secondary hepatic malignancies.  Intern Med J. 2005;  35 222-227
• 37 Popperl G, Helmberger T, Munzing W, Schmid R, Jacobs T F, Tatsch K. Selective internal radiation therapy with SIR-Spheres in patients with nonresectable liver tumors.  Cancer Biother Radiopharm. 2005;  20 200-208
• 38 Lau W Y, Ho S, Leung T W et al.. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of ⁹⁰Y yttrium microspheres.  Int J Radiat Oncol Biol Phys. 1998;  40 583-592
• 39 Lau W Y, Ho S, Leung W T, Chan M, Lee W Y, Johnson P J. What determines survival duration in hepatocellular carcinoma treated with intraarterial Yttrium-90 microspheres?.  Hepatogastroenterology. 2001;  48 338-340
• 40 Sasson A R, Sigurdson E R. Surgical treatment of liver metastases.  Semin Oncol. 2002;  29 107-118
• 41 Lewandowski R J, Thurston K G, Goin J E et al.. Yttrium-90 microsphere (TheraSphere) treatment for unresectable metastatic colorectal cancer to the liver: treatment response at targeted doses of 135-150 Gy as measured by 18FDG-PET and CT imaging.  J Vasc Interv Radiol. 2005;  16 1641-1651
• 42 Wong C Y, Salem R, Qing F et al.. Metabolic response after intraarterial ⁹⁰Y-glass microsphere treatment for colorectal liver metastases: comparison of quantitative and visual analyses by 18F-FDG PET.  J Nucl Med. 2004;  45 1892-1897
• 43 Wong C Y, Salem R, Raman S, Gates V L, Dworkin H J. Evaluating ⁹⁰Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI.  Eur J Nucl Med Mol Imaging. 2002;  29 815-820
• 44 Gray B, Van Hazel G, Hope M et al.. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer.  Ann Oncol. 2001;  12 1711-1720
• 45 Stubbs R S, Cannan R J, Mitchell A W. Selective internal radiation therapy with ⁹⁰yttrium microspheres for extensive colorectal liver metastases.  J Gastrointest Surg. 2001;  5 294-302
• 46 Stubbs R S, Cannan R J, Mitchell A W. Selective internal radiation therapy (SIRT) with ⁹⁰yttrium microspheres for extensive colorectal liver metastases.  Hepatogastroenterology. 2001;  48 333-337
• 47 Rubin D, Nutting C, Jones B. Metastatic breast cancer in a 54-year-old woman: integrative treatment with yttrium-90 radioembolization.  Integr Cancer Ther. 2004;  3 262-267
• 48 Boan J F, Martinez A, Sangro B, Rodriguez J, Penuelas I, Richter J A. European Journal of Nuclear Medicine and Molecular Imaging.  2004;  31(suppl 2) , Abstract P954
• 49 Coldwell D, Nutting C, Kennedy A S. Initial clinical results in the treatment of unresectable hepatic tumors with resin-based yttrium-90 radioembolization. In: Cardiovascular and Interventional Radiology Society of Europe (CIRSE), 2004. 
• 50 Wong C Y, Qing F, Savin M et al.. Reduction of metastatic load to liver after intraarterial hepatic yttrium-90 radioembolization as evaluated by [18F]fluorodeoxyglucose positron emission tomographic imaging.  J Vasc Interv Radiol. 2005;  16 1101-1106
• 51 Murthy R, Xiong H, Nunez R et al.. Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results.  J Vasc Interv Radiol. 2005;  16 937-945
• 52 Coldwell D, Nutting C. Treatment of hepatic metastases from breast cancer with yttrium-90 SIR-Spheres radioembolization. In: Society of Interventional Radiology Annual Meeting. New Orleans, LA; 2005
• 53 Rhee T K, Omary R A, Gates V et al.. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma.  J Vasc Interv Radiol. 2005;  16 1085-1091